Call for more information following mifepristone registration

Longstanding medical abortion advocate Professor Caroline de Costa said the first ‘real-world’ study from Marie Stopes abortion clinics, published in the MJA, highlighted issues with implications for the national provision of the drug.

Mifepristone has been available in Australia since 2006 through the TGA Authorised Prescriber Scheme but, under the provisions of registration, the drug (mifepristone linepharma) will now be distributed through MS Health, a not-for-profit pharmaceutical subsidiary of Marie Stopes